Home / LARGE1 Knockout Cell Lines

LARGE1 Knockout Cell Lines

Gene: LARGE1

Official Full Name: LARGE xylosyl- and glucuronyltransferase 1provided by HGNC

Gene Summary: This gene encodes a member of the N-acetylglucosaminyltransferase gene family. It encodes a glycosyltransferase which participates in glycosylation of alpha-dystroglycan, and may carry out the synthesis of glycoprotein and glycosphingolipid sugar chains. It may also be involved in the addition of a repeated disaccharide unit. The protein encoded by this gene is the glycotransferase that adds the final xylose and glucuronic acid to alpha-dystroglycan and thereby allows alpha-dystroglycan to bind ligands including laminin 211 and neurexin. Mutations in this gene cause several forms of congenital muscular dystrophy characterized by cognitive disability and abnormal glycosylation of alpha-dystroglycan. Alternative splicing of this gene results in multiple transcript variants that encode the same protein. [provided by RefSeq, May 2018]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO33442 LARGE1 Knockout cell line (HEK293) Human LARGE1 1:3~1:6 Negative Online Inquiry
KO33443 LARGE1 Knockout cell line (A549) Human LARGE1 1:3~1:4 Negative Online Inquiry

Background

LARGE1 Gene Knockout Cell Lines are genetically modified cellular models designed to explore the functional roles of the LARGE1 gene, which encodes a glycosyltransferase involved in the synthesis of glycosaminoglycans. These cell lines are created through advanced CRISPR-Cas9 gene editing technology, facilitating precise disruptions of the LARGE1 gene, which is crucial for understanding its contribution to various biological processes and diseases, including congenital disorders and certain cancers.

The primary function of LARGE1 is to modify the structure of heparan sulfate, a key component of the extracellular matrix and cell surface, influencing cell signaling, migration, and growth. By utilizing LARGE1 Gene Knockout Cell Lines, researchers can investigate the gene's role in cellular behavior under disease conditions, elucidate molecular pathways affected by its absence, and assess potential therapeutic targets for drug development.

Scientifically, these cell lines hold significant importance in both basic and applied research. They can be employed to study the mechanics of glycosylation in cancer biology, tissue regeneration, and developmental biology, thereby advancing our understanding of how modified glycosaminoglycan structures contribute to pathology and health. In clinical settings, insights gained from these models can pave the way for innovative treatments tailored to mitigate the effects of LARGE1-related disorders.

Compared to conventional cell lines, LARGE1 Gene Knockout Cell Lines deliver distinct advantages, including a more thorough representation of genetic variability and precise gene disruption that can mimic human disease more accurately. This specificity enables researchers and clinicians to generate reliable data that translate more effectively into clinical applications.

As a leading provider of advanced biological research tools, our expertise in genetic engineering ensures that our LARGE1 Gene Knockout Cell Lines are rigorously validated and optimized for performance in your experiments. Elevate your research with these precise tools designed for breakthrough discoveries in molecular and cellular biology.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.